Nutanix Prices ARR Growth Before the Convertible Cash Test

Summary: Nutanix (NASDAQ: NTNX) reports fourth-quarter and fiscal-year 2026 results on August 26 after the U.S. close, with a 4:30 p.m. EDT call. The latest available quote is $66.44 from an after-hours feed, down 0.33%, with a $16.387 billion market capitalization. Q3 ARR grew 15% to $2.43 billion and free cash flow was $197.2 million, but the April 30 balance sheet carried $1.347 billion of convertible senior notes, $725.6 million of stockholders' deficit, and 21.5 million potentially dilutive shares tied to notes and equity plans. The reference-only base case clears 10%, but the credible downside is wider than 5% and current execution evidence is incomplete. This is a Watchlist research note, not an order.

Run: 2026-08-26 07:31:40 Asia/Singapore

Direction: Long only

Classification: Watchlist for research, Reject for current execution

Holding window: Through September 30, 2026, after the August 26 Q4 event and the next cash, note, and denominator update

Opportunity Ranking

Rank	Candidate	Direction	Mispricing	Evidence Freshness	Catalyst Window	Positioning	10/5 Status	Tradeability	Main Rejection Risk
1	Nutanix (NTNX)	Long	ARR and hybrid-cloud AI adoption may be underweighted, but ARR timing, convertible notes, SBC, repurchases, and cash conversion are unresolved	May 27 Q3 release, August 6 official Q4 notice, live quote	August 26 Q4 and FY26 results	Nine-month repurchases and a $750M authorization increase disclosed; live short, options, dealer, fund, and book data missing	Watchlist, reference-only	Liquid Nasdaq common stock in ordinary conditions, but current book and exit gates unverified	$1.347B convertible notes, $725.6M stockholders' deficit, SBC, and event-gap risk
2	Best Buy (BBY)	Long	A 15.79 feed P/E may underprice cash generation and a positive comp, but CEO transition, inventory, tariffs, and the Q2 margin test remain	May 28 Q1 release, August 27 official event, live quote	August 27 Q2 results	FY27 repurchase plan and dividends disclosed; live positioning missing	Watchlist, reference-only	Liquid NYSE common stock, but current book and exit gates unverified	Consumer demand, product-cycle, tariff, and leadership-transition risk
3	Affirm (AFRM)	Long	Platform growth may outpace the market's credit concerns, but a 69.59 feed P/E leaves a high proof burden	Q3 results and August 27 official event window, live quote	August 27 Q4 FY26 results	No live positioning evidence	Reject for this screen	Liquid Nasdaq common stock, but credit and funding state need a fresh filing	Provision, funding, consumer credit, and valuation risk
4	Standard Nuclear (STDN)	Long	Nuclear-fuel scarcity may be valuable, but a 16.50% one-day move and thin public operating history do not establish an equity edge	August 19 official event notice and live quote	August 26 Q2 results	Price and volume only; causal flows missing	Reject for this screen	Execution quality and exit liquidity are not established	Newly public operating, financing, and liquidity uncertainty

Selected opportunity: Nutanix long research, with execution blocked.

Why this one now: Nutanix has the highest combination of catalyst urgency, primary evidence, and ordinary-stock tradeability in this screen. Its Q3 filing exposes both sides of the disagreement: 15% ARR growth, 3.4-year average contract duration, and $197.2 million of free cash flow against convertible notes, stock compensation, repurchases, and a negative book-equity balance. No dedicated Nutanix article or signal exists in the repository.

What should surprise the reader: The important result is not another AI partnership announcement. It is whether ARR and contract duration convert into recognized revenue and cash without allowing convertible claims, stock compensation, or issuer repurchases to obscure the common denominator.

Why This Is the Best Opportunity Right Now

Nutanix has a dated event inside the next U.S. session and a more complete recurring-revenue baseline than the other candidates. Q3 ARR grew 15%, revenue grew 10%, average contract duration rose to 3.4 years, GAAP operating margin reached 10.0%, and free cash flow was $197.2 million. Management's Q4 outlook was $725 million to $745 million of revenue and fiscal-year free cash flow of $760 million to $780 million.

The selection is not a claim that Nutanix is cheap. The market can value a hybrid-cloud platform at a premium because the ARR is real and the customer base is large. The less obvious question is how much of the operating improvement belongs to common equity after $1.347 billion of convertible senior notes, $263.1 million of year-to-date stock compensation, $257.9 million of year-to-date common repurchases, and the potential share count are reconciled.

Why This Can Move More Than 5% Soon

The official Nutanix notice places the fiscal Q4 and full-year 2026 results after the August 26 close, with a 4:30 p.m. EDT webcast. Q3 guidance framed the immediate test at $725 million to $745 million of revenue, a 21% to 23% non-GAAP operating margin, and approximately 292 million diluted shares. A change in ARR growth, contract duration, RPO conversion, revenue timing, free cash flow, or the fiscal 2027 guide can move the multiple quickly.

That is catalyst risk, not a forecast. The long hurdle still requires a base case above 10% and a credible adverse case no worse than -5% from a verified executable entry. The current reference-only map fails the adverse test and the gross reward-to-adverse-risk test.

10/5 Asymmetry Gate

The calculation uses $66.44 as a reference price, not an executable entry. The live finance feed provides the price, range, volume, market capitalization, and change, but no verified bid, ask, spread, depth, venue quality, or realistic exit price. The Q4 event can also gap beyond any stop order.

The reference-only base case is $80.00, or +20.4%. The modeled bottom case is $58.00, or -12.7%. Gross base-to-adverse reward is approximately 1.61:1, below the Desk's 2:1 threshold, before spread, slippage, fees, taxes, and carrying costs. The entry is null and the adverse case fails the long 5% bound. This is Watchlist for research and Reject for current execution.

What Should Surprise the Reader

Nutanix's Q3 ARR grew 15%, while revenue grew 10%. That is constructive, but ARR is a company-defined performance measure, not GAAP revenue. Nutanix says its ARR assumes contracts expiring in the period renew on existing terms and does not adjust for future cancellations, expansions, contractions, or price changes. Contract duration rising to 3.4 years can improve the ARR and timing picture without proving that the same economics will be recognized as revenue or cash.

The second surprise is the capital bridge. April 30 cash and short-term investments totaled approximately $2.018 billion, against $1.347 billion of convertible senior notes and total liabilities of $4.144 billion. Stockholders' deficit was $725.6 million. That is not a claim that the common is worthless. It is a reason to require a current cash, note, and denominator bridge before turning ARR into per-share value.

The third surprise is capital return quality. Nutanix repurchased $257.9 million of common stock in the first nine months and partially repurchased 2027 notes for $95.5 million. It also recorded $11.3 million of inducement expense related to that note repurchase and reported $263.1 million of stock-based compensation for the nine months. A repurchase can improve the common denominator while cash leaves the balance sheet and note claims remain relevant.

The Setup

Fact: Nutanix's Q3 fiscal 2026 ARR was $2.43 billion, up 15% year over year, and average contract duration was 3.4 years versus 3.1 years a year earlier. Nutanix Q3 FY26 results

Fact: Q3 revenue was $703.1 million, up 10%. GAAP operating income was $70.5 million, a 10.0% margin, and non-GAAP operating income was $156.5 million, a 22.3% margin. Nutanix Q3 FY26 results

Fact: Q3 operating cash flow was $207.5 million and free cash flow was $197.2 million. For the nine months ended April 30, operating cash flow was $601.7 million and free cash flow was $563.1 million. Nutanix Q3 FY26 results

Fact: At April 30, Nutanix reported cash of $718.8 million, short-term investments of $1.299 billion, convertible senior notes net of $1.347 billion, total liabilities of $4.144 billion, and stockholders' deficit of $725.6 million. Nutanix Q3 FY26 results

Fact: The April 30 balance sheet and earnings reconciliation included $21.5 million of potentially dilutive shares related to convertible senior notes and employee equity plans. Nine-month stock-based compensation was $263.1 million. Nutanix Q3 FY26 results

Fact: Q3 cash flows showed $257.9 million of common repurchases, a $95.5 million partial repurchase of the 2027 notes, and $11.3 million of inducement expense from that note repurchase. The company also announced a $750 million increase to its common-stock repurchase authorization at Investor Day. Nutanix Q3 FY26 results

Fact: Nutanix's Q4 fiscal 2026 outlook was $725 million to $745 million of revenue, a 21% to 23% non-GAAP operating margin, and approximately 292 million diluted shares. Full-year free cash flow was guided to $760 million to $780 million. Nutanix Q3 FY26 results

Fact: Nutanix's official notice schedules fiscal Q4 and FY26 results after the U.S. market close on August 26, with a 4:30 p.m. EDT call. Nutanix Q4 FY26 event notice

Inference: The market may be underweighting the value of Nutanix's recurring platform growth, longer contracts, and AI-related product expansion. The counter-inference is that ARR is not revenue, RPO is not cash, and the premium must survive note claims, stock compensation, repurchases, and a negative book-equity balance.

The Market Price

The latest available finance-feed observation for NTNX was $66.44, timestamped 2026-08-25 21:51:16 UTC. The feed reported a change of -$0.22, or -0.32993%, an open of $66.40, high of $67.51, low of $65.51, volume of 2,542,726, and market capitalization of $16.387 billion. NTNX finance quote

This is an after-hours feed observation tied to the latest available trade, not a verified regular-session executable quote. A live bid, ask, spread, depth, venue, volume quality, and realistic exit price were not verified. The balance-sheet and cash-flow facts above are from April 30, not the quote timestamp, so no current EV or net-cash claim is made.

The Mispricing

The candidate mispricing is an ARR-to-common-equity conversion disagreement. At $66.44, the market may be assigning too little value to a hybrid-cloud platform with 15% ARR growth, 3.4-year average contract duration, 30,000-plus customers, strong gross margins, and a visible AI product path. A Q4 result that confirms recurring growth and raises fiscal 2027 cash guidance could support a higher multiple.

The market may be right because Nutanix's ARR is a non-GAAP company-defined metric, revenue growth was lower than ARR growth, and the Q4 event carries timing risk. The balance sheet has convertible notes, leases, substantial deferred revenue, a negative stockholders' balance, and a potential common denominator that is larger than basic shares. The $750 million repurchase authorization is potential demand, not a floor.

The long case needs a specific state change: ARR, contract duration, and RPO must convert into recognized revenue and cash, while note claims, SBC, and repurchases produce a transparent per-share bridge. An AI partnership or ARR headline without that reconciliation does not close the gap.

The Positioning

The strongest observable positioning facts are issuer actions. Nutanix repurchased $257.9 million of common stock in the first nine months, partially repurchased $95.5 million of 2027 notes, and announced a $750 million increase to the common repurchase authorization. These actions show capital allocation, but they do not prove that the market is crowded or that the common is protected.

I do not have sufficient reliable data to quantify current short interest, borrow, options open interest, dealer gamma, fund flows, institutional ownership changes, or the live order book accurately. Positioning confidence is 3/5. The price and volume feed show participation, not its cause.

The Catalyst

Q4 and FY26 results, August 26 at 4:30 p.m. EDT. The official event notice confirms the timing. Test revenue against $725 million to $745 million guidance, ARR, average contract duration, RPO, subscription revenue, GAAP and non-GAAP margins, free cash flow, and the fiscal 2027 guide. Nutanix Q4 FY26 event notice
ARR and contract-duration conversion. Separate ARR methodology, current and non-current RPO, subscription revenue, deferred revenue, billings, renewals, and recognized cash. A longer contract can change timing without proving customer lifetime value.
AI and hybrid-cloud adoption. Separate announced Agentic AI, modern-applications, external-storage, and service-provider capabilities from paid adoption, bookings, customer expansion, revenue, and margin.
Cash and note bridge. Reconcile operating cash, investments, capex, debt service, convertible-note repurchase or conversion, stock compensation, leases, common repurchases, and diluted shares.
Next filing. The next quarterly balance sheet and share-count disclosure must show whether the operating result improved common value after notes and repurchases, not merely whether the share count moved.

The cheapest falsification sequence is the Q4 ARR and contract-duration table, the revenue and RPO conversion, and the cash, note, SBC, repurchase, and denominator reconciliation. If the guide fails first, the balance sheet does not rescue the platform multiple.

The Payoff

The top case is a Q4 beat and a stronger fiscal 2027 guide, with ARR above the current growth path, contract duration holding, AI adoption becoming paid revenue, free cash flow remaining strong, and repurchases producing a clean common denominator. The base case is guide-compliant performance with healthy ARR but enough timing, note, SBC, and cash uncertainty to keep the multiple from fully expanding. The bottom case is a guide cut, weak ARR or RPO conversion, cash deterioration, note-related dilution or expense, or a market compression of the hybrid-cloud multiple. These are scenario assumptions, not sourced price targets.

Price Target and Probability Map

This is a price-only research map through September 30, 2026. It is not an executable quote, a stop, or personalized financial advice.

Scenario	Probability	Target / Level	Return / Payoff	Horizon	Conditions	Evidence Quality
Top Case	25%	$90.00	+35.5%	Through Sep. 30	Q4 beats revenue and ARR expectations, contract duration holds, AI adoption becomes paid growth, FCF guidance rises, and note and repurchase actions improve the common bridge.	Low to Medium
Base Case	50%	$80.00	+20.4%	Through Sep. 30	Q4 meets or modestly raises the guide, ARR remains near 15% growth, cash generation holds, and note and denominator effects remain manageable.	Medium
Bottom Case	25%	$58.00	-12.7%	Through Sep. 30	ARR or revenue timing disappoints, the guide falls, AI adoption stays narrative-only, FCF weakens, or convertible and denominator concerns compress the multiple.	Medium
Invalidation	n/a	No responsible fixed price	n/a	Any point	Q4 operating, cash, note, denominator, or execution evidence breaks the ARR-to-common-equity re-rating case.	High

Probability-weighted expected price: 0.25 × $90.00 + 0.50 × $80.00 + 0.25 × $58.00 = $77.00, or approximately +15.9% versus the $66.44 reference before costs.

Net EV: cannot be computed responsibly. There is no verified executable entry, live spread, slippage, exit liquidity, or event-gap estimate. The quote and the April 30 cash, notes, leases, deferred revenue, and denominator data do not share one auditable timestamp. The $77.00 figure is a price-only expected value, not net trade EV.

Current market level and timestamp: $66.44 at 2026-08-25 21:51:16 UTC, after-hours finance-feed observation.

Primary instrument: NTNX common stock, Nasdaq, USD.

10/5 favorable base move: +20.4% from the reference only.

10/5 credible adverse move: -12.7% in the modeled bottom case.

10/5 measurement basis: reference-only, not verified entry.

10/5 status: Reject for current execution, Watchlist for research.

Confidence: Medium on Q3 and event facts; Low on the forward price map, paid AI conversion, and current execution state.

The Kill Shot

The strongest counterparty argument is that Nutanix is correctly priced for a good but maturing recurring-revenue software business. ARR is a management-defined metric that assumes renewal on existing terms and does not forecast future cancellations or expansion. Revenue grew 10%, below ARR growth. The Q4 guide may be met without a new growth leg, while convertible notes, $263.1 million of year-to-date stock compensation, and a $725.6 million stockholders' deficit make the common-share bridge less clean than the ARR headline.

The load-bearing assumption for the long is that ARR and contract duration will convert into paid, durable revenue and cash faster than note, SBC, and valuation risks dilute the per-share outcome. A correct long thesis can still lose through an earnings gap, contract timing, public-cloud competition, AI adoption delay, a guide cut, note conversion, cash deployment, or repurchases that fail to create durable common value.

What Could Go Wrong

ARR quality: ARR assumes expiring contracts renew on existing terms and is not GAAP revenue or a forecast of recognized cash.
Timing: Contract duration and RPO can pull future work into the metric without changing near-term revenue or collections.
AI monetization: Product announcements and partnerships may not produce paid customers, expansion, margin, or cash.
Convertible notes: $1.347 billion of notes and 21.5 million potentially dilutive shares can matter even when repurchases reduce the basic denominator.
Stock compensation: $263.1 million of nine-month SBC is a common-share economic cost excluded from non-GAAP margins.
Cash deployment: Cash and short-term investments can be spent on notes, repurchases, investments, capex, or operating needs.
Event gap: The result is after close and a stop order cannot bound an overnight gap, halt, or unavailable liquidity.
Market structure: Current top-of-book, spread, depth, venue quality, volume quality, and exit liquidity are unverified.

What Would Prove This Wrong

Q4 ARR, average contract duration, revenue, RPO, subscription revenue, or the fiscal 2027 guide weakens materially.
AI, modern-applications, external-storage, or service-provider adoption does not produce paid revenue, expansion, or margin evidence.
Cash flow weakens after deferred revenue, receivables, commissions, investments, capex, notes, leases, and repurchases are reconciled.
Convertible-note conversion, inducement expense, interest, or potential dilution materially reduces common-share value.
Actual repurchase cash and shares retired do not support denominator improvement, or the authorization is paused.
Current cash, short-term investments, notes, leases, diluted shares, or claims cannot be reconciled to a fresh filing.
A fresh regular-session quote, spread, depth, venue, volume-quality, or exit-liquidity check fails. That cancels execution even if the research thesis remains open.

Risk Audit

Risk control	Required observation	Current state
Recurring growth	ARR, contract duration, subscription revenue, RPO, billings, renewals, and recognized revenue	Q3 ARR +15%, duration 3.4 years, revenue +10%; Q4 pending
AI conversion	Agentic AI, modern-applications, external-storage, and service-provider adoption translated into paid customers and revenue	Product and partnership evidence exists; paid Q4 conversion pending
Cash conversion	OCF and FCF after deferred revenue, receivables, commissions, investments, capex, notes, and leases	Nine-month OCF $601.7M and FCF $563.1M; current bridge pending
Capital stack	Cash, short-term investments, convertible notes, leases, interest, inducement expense, and potential dilution	April 30 balance sheet known; Q4 bridge pending
Capital return	Repurchases paid, notes repurchased, shares retired, authorization, SBC, and diluted shares	Nine-month common repurchases $257.9M; current share count pending
Positioning	Short interest, borrow, options, dealer flow, fund flow, ownership, and live book	Not verified; positioning capped at 3/5
Market structure	Regular-session quote, bid, ask, spread, depth, venue, volume quality, and exit liquidity	Not verified

The $58.00 bottom is a scenario, not a guaranteed stop. No price floor is asserted.

Best Trade Strategy

Expression: Conditional NTNX common shares only, after the August 26 Q4 report and the ARR, revenue, cash, convertible-note, repurchase, and denominator bridge are independently re-underwritten.

Entry state: entry.price = null. Do not open a position from the $66.44 after-hours feed. A future entry would require a fresh regular-session quote, acceptable spread and depth, venue and volume-quality checks, realistic exit liquidity, Q4 ARR and contract duration, revenue and RPO conversion, paid AI evidence, cash after notes and capex, current note terms, actual repurchases, and diluted shares. A future quote does not inherit today's scenario arithmetic.

Targets: top $90.00, base $80.00, bottom $58.00, with probabilities 25%, 50%, and 25%.

Invalidation: Remove the long research case if ARR and contract duration fail to convert, paid AI adoption remains narrative-only, cash after notes and capex weakens, the guide falls, actual repurchases do not reduce the denominator, or current execution gates fail. Cancel execution whenever a required current market or fundamental gate is missing.

Monitoring: August 26 Q4 release and call; ARR; average contract duration; current and non-current RPO; subscription revenue; Q4 and FY27 guide; Agentic AI and external-storage adoption; operating cash and FCF; cash and short-term investments; notes and note repurchase or conversion; SBC; common repurchases; diluted shares.

Do not trade: no options, leverage, margin, market orders, price-floor logic, or entry based only on ARR, a contract-duration headline, AI partnerships, cash and investments, a repurchase authorization, or non-GAAP FCF.

Sources

Source	Tier	Date / timestamp	Use
Nutanix Q3 FY26 results	Company primary release	May 27, 2026; quarter ended Apr. 30, 2026	ARR, contract duration, revenue, RPO, cash flow, cash, investments, notes, SBC, repurchases, denominator, and guidance
Nutanix Q4 FY26 event notice	Company primary event notice	August 6, 2026; event August 26 at 4:30 p.m. EDT	Catalyst timing
NTNX finance quote	Market-data feed	Latest trade August 25, 2026 21:51:16 UTC	$66.44 reference, change, range, volume, and market capitalization
Best Buy Q1 FY27 results	Company primary release	May 28, 2026	Ranked alternative comps, cash flow, guidance, CEO transition, and capital return
Best Buy Q2 FY27 event page	Company primary event page	August 27, 2026	Ranked alternative catalyst
BBY finance quote	Market-data feed	Latest trade August 25, 2026 23:15:00 UTC	Ranked alternative price and valuation
Affirm quarterly results	Company primary results page	Retrieved August 26, 2026	Ranked alternative operating and credit evidence
AFRM finance quote	Market-data feed	Latest trade August 25, 2026 21:35:00 UTC	Ranked alternative price and valuation
Standard Nuclear Q2 event notice	Company primary event notice	August 2026; event August 26	Ranked alternative catalyst and evidence boundary
STDN finance quote	Market-data feed	Latest trade August 25, 2026 23:15:00 UTC	Ranked alternative price, move, range, and volume

Research Quality Scorecard

This is the canonical Desk rubric, scored 1 to 5 per criterion.

Criterion	Score	Reason
Market disagreement	4/5	ARR growth and AI optionality conflict with note, SBC, denominator, and valuation risk
Evidence base	5/5	Fresh official Q3 filing, official Q4 event, and current market feed
Positioning and flows	3/5	Issuer repurchases and note repurchase are known; live positioning and order-book evidence are missing
Catalyst path	5/5	Official event has a date and measurable ARR, revenue, cash, note, and denominator tests
Payoff architecture	3/5	Reference-only map is favorable, but adverse risk exceeds 5% and gross ratio is below 2:1
Invalidation discipline	4/5	Operating, cash, note, denominator, and execution breaks are monitorable
Differentiated insight	4/5	Tests ARR and AI conversion against convertible-note and stock-compensation economics
Client value	3/5	Useful decision map even if the correct action is to wait

Total: 31/40. Classification: Watchlist. A score cannot override the failed 10/5 adverse bound, sub-2:1 ratio, or incomplete execution audit.

Bottom Line

Nutanix has a credible recurring-revenue and hybrid-cloud growth engine, but the market is entitled to demand proof that ARR and AI adoption become cash after notes, SBC, leases, and repurchases. The August 26 event is the adjudicating test. The reference-only map offers upside, yet the modeled downside is wider than 5%, the gross ratio is below 2:1, the quote is after-hours, and the common-share bridge is not current. Keep entry.price null and the signal blocked until ARR converts, cash and notes reconcile, and the denominator is verified.

AI Illustration Prompt

Editorial financial illustration for The Mispricing Desk: a realistic after-hours hybrid-cloud control room centered on a glass ledger labeled “Nutanix Q4 FY26,” with a quiet server aisle and a secure AI workflow map in the background. In the foreground, place four physical objects on a graphite institutional desk: a recurring-revenue contract stack marked “ARR $2.43B,” a translucent RPO panel marked “RPO $3.08B,” a heavy brushed-steel convertible note plate marked “notes $1.347B,” and a cash-and-investments card marked “$2.018B.” Beside them, show a shrinking ring of common-share digits crossed by a thin stock-compensation line marked “SBC $263.1M,” a repurchase receipt marked “$257.9M,” and an unfilled order ticket marked “ENTRY UNVERIFIED.” Add a calendar card stamped “August 26 Q4,” with a subtle split rail labeled “ARR” and “recognized cash.” Deep navy, graphite, paper white, muted cobalt, brushed steel, and one controlled amber risk accent; sober Bloomberg Markets or Financial Times realism; no generic candlestick chart, no neon robot, no bull or bear mascot, no hype; subtle readable “The Mispricing Desk” watermark in the lower-right corner.